hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
8.1.2 Human health impact evidence Comprehensive epidemiological investigations involving over 10,000 participants provide compelling evidence of EED reproductive toxicity
For example, beta-blockers are commonly prescribed to manage high blood pressure and heart rate, while conditions like anemia or thyroid disorders can lead to abnormal fluctuations
Always inspect your vial of bac water before using it
6J), indicative of SASP, and elevated Urea levels in the blood (e.g
Common side effects of B12 injections may include mild pain at the injection site, diarrhea, itching, or swelling